Dr Patrick Harris
Dr

Patrick Harris

Email: 
Phone: 
+61 7 334 65476

Background

Dr Patrick Harris is an Infectious Disease Physician, Medical Microbiologist and NHMRC Emerging Leader (EL2) Fellow at The University of Queensland Centre for Clinical Research (UQCCR).

Dr. Harris obtained a BSc in Psychology and Anthropology from Durham University, prior to acquiring his medical degree from University College London Medical School. Following postgraduate training in the UK, he worked as a clinical lecturer at the College of Medicine in Malawi, before completing specialist training in infectious diseases and microbiology in Australia. For his final year of training he was a Senior Visiting Fellow in Infectious Disease at the National University Hospital in Singapore. He completed his PhD in 2018 under the supervision of Prof. David Paterson, and now is a Group Leader at UQCCR, with a research focus on the diagnosis and clinical management of infections caused by multi-drug resistant bacteria

Availability

Dr Patrick Harris is:
Available for supervision

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, University of London
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Clinical trials

    Assessing the clinical impact of novel antibiotic treatment strategies for bloodstream infections

  • Antibiotic resistance

    Resistance in gram-negative pathogens such as E. coli, Klebsiella and Enterobacter

  • Clinical application of genomics

    Use of whole genome sequencing in clinical microbiology

Research impacts

He has published more than 190 peer-reviewed articles, many as first or senior author, including JAMA, the Lancet, Lancet Infectious Diseases and Clinical Infectious Diseases. He was a lead investigator for the MERINO trial: an international multicentre study to compare carbapenem-sparing treatment options for ESBL and AmpC-producing species. This has been the first large RCT to specifically address this question, using a protocol developed and endorsed by the Australasian Society for Infectious Diseases Clinical Research Network (ASID-CRN). https://clinicaltrials.gov/ct2/show/NCT02176122. This was followed by the MERINO-2 trial: a randomised controlled trial of meropenem versus piperacillin-tazobactam for treatment of bloodstream infections due to AmpC-producing Enterobacter, Citrobacter, Serratia, Providencia and Morganella: https://clinicaltrials.gov/ct2/show/NCT02437045. His other main research interest includes the application of whole genome sequencing to clinical microbiology. He was the clinical lead for the Queensland Genomics Clinical Demonstration Project: Whole genome sequencing to track, treat and prevent nosocomial infections. This project has successfuly integrated a genomics workflow within Queensland health, to support outbreak response and surveillance of hospital acqured multi-drug resistant infections: Hospital acquired infections – Queensland Genomics

Search Professor Patrick Harris’s works on UQ eSpace

258 works between 2009 and 2025
All (258) Journal Article (224) Book Chapter (2) Conference Publication (23) Other Outputs (9)

221 - 240 of 258 works

2016

Journal Article

Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches

Roberts, Matthew J., Bennett, Harrison Y., Harris, Patrick N., Holmes, Michael, Grummet, Jeremy, Naber, Kurt and Wagenlehner, Florian M. E. (2016). Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology, 104, 11-21. doi: 10.1016/j.urology.2016.12.011

Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches

2016

Journal Article

Detection of carbapenemase activity in Enterobacteriaceae using LC-MS/MS in comparison with the neo-rapid CARB kit using direct visual assessment and colorimetry

Huber, Charlotte A., Sidjabat, Hanna E., Zowawi, Hosam M., Kvaskoff, David, Reed, Sarah, McNamara, John F., McCarthy, Kate L., Harris, Patrick, Toh, Benjamin, Wailan, Alexander M. and Paterson, David L. (2016). Detection of carbapenemase activity in Enterobacteriaceae using LC-MS/MS in comparison with the neo-rapid CARB kit using direct visual assessment and colorimetry. Journal of Microbiological Methods, 131, 68-72. doi: 10.1016/j.mimet.2016.10.005

Detection of carbapenemase activity in Enterobacteriaceae using LC-MS/MS in comparison with the neo-rapid CARB kit using direct visual assessment and colorimetry

2016

Journal Article

Central nervous system nocardiosis in Queensland: a report of 20 cases and review of the literature

Rafiei, Nastaran, Peri, Anna Maria, Righi, Elda, Harris, Patrick and Paterson, David L. (2016). Central nervous system nocardiosis in Queensland: a report of 20 cases and review of the literature. Medicine, 95 (46) e5255, e5255. doi: 10.1097/MD.0000000000005255

Central nervous system nocardiosis in Queensland: a report of 20 cases and review of the literature

2016

Journal Article

An outbreak of scrub typhus in military personnel despite protocols for antibiotic prophylaxis: doxycycline resistance excluded by a quantitative PCR-based susceptibility assay

Harris, Patrick N. A., Oltvolgyi, Csongor, Islam, Aminul, Hussain-Yusuf, Hazizul, Loewenthal, Mark R., Vincent, Gemma, Stenos, John and Graves, Stephen (2016). An outbreak of scrub typhus in military personnel despite protocols for antibiotic prophylaxis: doxycycline resistance excluded by a quantitative PCR-based susceptibility assay. Microbes and Infection, 18 (6), 406-411. doi: 10.1016/j.micinf.2016.03.006

An outbreak of scrub typhus in military personnel despite protocols for antibiotic prophylaxis: doxycycline resistance excluded by a quantitative PCR-based susceptibility assay

2016

Journal Article

Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing enterobacteriaceae

Ng, Tat Ming, Khong, Wendy X., Harris, Patrick N. A., De, Partha P., Chow, Angela, Tambyah, Paul A. and Lye, David C. (2016). Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing enterobacteriaceae. Plos One, 11 (4) e0153696, e0153696. doi: 10.1371/journal.pone.0153696

Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing enterobacteriaceae

2016

Journal Article

Colistin resistance: a major breach in our last line of defence

Paterson, David L. and Harris, Patrick N. A. (2016). Colistin resistance: a major breach in our last line of defence. The Lancet Infectious Diseases, 16 (2), 132-133. doi: 10.1016/S1473-3099(15)00463-6

Colistin resistance: a major breach in our last line of defence

2016

Journal Article

Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis

Harris, Patrick N. A., Wei, Jane Y., Shen, Andrew W., Abdile, Ahmed A., Paynter, Stuart, Huxley, Rachel R., Pandeya, Nirmala, Doi, Yohei, Huh, Kyungmin, O'Neal, Catherine S., Talbot, Thomas R. and Paterson, David L. (2016). Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis. Journal of Antimicrobial Chemotherapy, 71 (2) dkv346, 296-306. doi: 10.1093/jac/dkv346

Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis

2016

Conference Publication

Multi-drug Resistant Enterobacteriaceae from Bhutan: Whole Genome Sequencing of ESBL and Carbapenemase-producing Strains

Harris, Patrick N. A., Wailan, Alexander, Buckley, Cameron, Catchpoole, Elizabeth, Zowawi, Hosam M., Whiley, David, Tshokey, Tshokey, Sharma, Ragunath, Chong, Smathi and Paterson, David L. (2016). Multi-drug Resistant Enterobacteriaceae from Bhutan: Whole Genome Sequencing of ESBL and Carbapenemase-producing Strains. International Congress for Tropical Medicine and Malaria (ICTMM 2016), Brisbane Australia, 18-22 September 2016.

Multi-drug Resistant Enterobacteriaceae from Bhutan: Whole Genome Sequencing of ESBL and Carbapenemase-producing Strains

2016

Conference Publication

Mapping the global prevalence of resistance to antimicrobials in gram-negative urinary pathogens: a meta-analysis of contemporary studies

Harris, Patrick N. A., Zowawi, Hosam M., Banu, Shahera and Paterson, David L. (2016). Mapping the global prevalence of resistance to antimicrobials in gram-negative urinary pathogens: a meta-analysis of contemporary studies. The 55th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) / International Society of Chemotherapy (ISC)’s International Congress of Chemotherapy and Infection (ICC) - ICAAC/ICC, San Diego, CA, United States, 18-22 September 2016.

Mapping the global prevalence of resistance to antimicrobials in gram-negative urinary pathogens: a meta-analysis of contemporary studies

2015

Journal Article

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

Zowawi, Hosam M., Harris, Patrick N. A., Roberts, Matthew J., Tambyah, Paul A., Schembri, Mark A., Pezzani, M. Diletta, Williamson, Deborah A. and Paterson, David L. (2015). The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology, 12 (10), 570-584. doi: 10.1038/nrurol.2015.199

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

2015

Journal Article

Community-acquired pyelonephritis in pregnancy caused by KPC-producing Klebsiella pneumoniae

Khatri, Asma, Murphy, Nina Naeger, Wiest, Peter, Osborn, Melissa, Garber, Kathleen, Hecker, Michelle, Hurless, Kelly, Rudin, Susan D., Jacobs, Michael R., Kalayjian, Robert C., Salata, Robert A., Van Duin, David, Perez, Federico, Bonomob, Robert A., Paterson, David L. and Harris, Patrick N. A. (2015). Community-acquired pyelonephritis in pregnancy caused by KPC-producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 59 (8), 4375-4378. doi: 10.1128/AAC.00553-15

Community-acquired pyelonephritis in pregnancy caused by KPC-producing Klebsiella pneumoniae

2015

Journal Article

Editorial commentary: the new acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble

Paterson, David L. and Harris, Patrick N. A. (2015). Editorial commentary: the new acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble. Clinical Infectious Diseases, 61 (2), 155-156. doi: 10.1093/cid/civ227

Editorial commentary: the new acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble

2015

Journal Article

Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?

Harris, P. N. A., Alder, L. and Paterson, D. L. (2015). Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?. Pathology, 47 (4), 386-388. doi: 10.1097/PAT.0000000000000255

Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?

2015

Journal Article

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

Harris, Patrick N. A., Yin, Mo, Jureen, Roland, Chew, Jonathan, Ali, Jaminah, Paynter, Stuart, Paterson, David L. and Tambyah, Paul A. (2015). Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae. Antimicrobial Resistance and Infection Control, 4 (1) 14, 14.1-14.10. doi: 10.1186/s13756-015-0055-6

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

2015

Journal Article

Facing the challenge of multidrug-resistant gram-negative bacilli in Australia

Harris, Patrick, Paterson, David and Rogers, Benjamin (2015). Facing the challenge of multidrug-resistant gram-negative bacilli in Australia. Medical Journal of Australia, 202 (5), 243-246. doi: 10.5694/mja14.01257

Facing the challenge of multidrug-resistant gram-negative bacilli in Australia

2015

Journal Article

Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study

Harris, Patrick N. A., Le, Bich Diep, Tambyah, Paul, Hsu, Li Yang, Pada, Surinder, Archuleta, Sophia, Salmon, Sharon, Mukhopadhyay, Amartya, Dillon, Jasmine, Ware, Robert and Fisher, Dale A. (2015). Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study. Open Forum Infectious Diseases, 2 (2) ofv051, ofv051. doi: 10.1093/ofid/ofv051

Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study

2015

Journal Article

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

Harris, Patrick N. A., Peleg, Anton Y., Iredell, Jon, Ingram, Paul R., Miyakis, Spiros, Stewardson, Andrew J., Rogers, Benjamin A., McBryde, Emma S., Roberts, Jason A., Lipman, Jeff, Athan, Eugene, Paul, Sanjoy K., Baker, Peter, Harris-Brown, Tiffany and Paterson, David L. (2015). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 16 (1) 24, 24.1-24.8. doi: 10.1186/s13063-014-0541-9

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

2015

Journal Article

Clinical management of infections caused by enterobacteriaceae that express extended-spectrum β-Lactamase and AmpC enzymes

Harris, Patrick N. A. (2015). Clinical management of infections caused by enterobacteriaceae that express extended-spectrum β-Lactamase and AmpC enzymes. Seminars in Respiratory and Critical Care Medicine, 36 (1), 56-73. doi: 10.1055/s-0034-1398387

Clinical management of infections caused by enterobacteriaceae that express extended-spectrum β-Lactamase and AmpC enzymes

2015

Journal Article

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options?

Harris, Patrick N. A., Tambyah, Paul A. and Paterson, David L. (2015). β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options?. The Lancet Infectious Diseases, 15 (4), 475-485. doi: 10.1016/S1473-3099(14)70950-8

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options?

2014

Journal Article

Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults

Harris, Patrick N. A., Wang, Alvin D., Yin, Mo, Lee, Chun Kiat and Archuleta, Sophia (2014). Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. Lancet Infectious Diseases, 14 (11), 1043-1043. doi: 10.1016/S1473-3099(14)70976-4

Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults

Current funding

  • 2025 - 2030
    Comparative effectiveness of Class II/III medical devices to prevent bloodstream infections in central venous catheters: The IVCare adaptive platform RCT
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2025 - 2030
    IVCare Trial: Comparative Effectiveness of Devices to Prevent Bloodstream Infections in Central Venous Catheters
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2025 - 2029
    ROAD RCT: Resistance Optimised Antibiotic Dosing in critically ill patients - a Randomised Controlled Trial
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2025 - 2029
    ROAD RCT: Resistance Optimised Antibiotic Dosing in critically ill patients - a Randomised Controlled Trial
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2025 - 2029
    New diagnostic strategies for antibiotic-resistant infections
    NHMRC Investigator Grants
    Open grant
  • 2024 - 2025
    Testing EBL-1463 (a novel non-beta-lactam PBP inhibitor) against metallo-betalactamase producing Enterobacterales
    Mutabilis SAS
    Open grant
  • 2024 - 2026
    Reducing blood culture contamination with the use of a needle-less blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (The PIVO Trial)
    Becton, Dickinson and Company
    Open grant
  • 2024 - 2028
    Unlocking the gut microbiome to track the spread of AMR genes and pathogens
    MRFF - Global Health Initiative
    Open grant
  • 2024 - 2025
    A Rapid, Routine Genomics Service for Clinical Haematology (QLD Health Targeted CRF led by RBWH Metro North Health)
    Metro North Hospital and Health Service
    Open grant
  • 2023 - 2026
    New diagnostic strategies for antibiotic-resistant infections
    Queensland Health Clinical Research Fellowships
    Open grant
  • 2023 - 2025
    Performance of emerging diagnostic techniques for the diagnosis of severe infections in neutropenic patients with haematological malignancies
    Microbio Ltd
    Open grant
  • 2023 - 2027
    Accelerating pathogen detection and antibiotic resistance prediction in children with suspected sepsis
    The Children's Hospital Foundation
    Open grant
  • 2018 - 2030
    Investigator Driven Randomized Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection (the GAME CHANGER trial)
    Shionogi & Company, Limited
    Open grant

Past funding

  • 2023 - 2025
    Development of Wastewater-based epidemiology as a complementary approach for antimicrobial resistance surveillance
    Heidi-CSIRO IDR and AMR Projects
    Open grant
  • 2023 - 2024
    Improving management of fungal infections during blood cancer treatment
    Gilead Australia Fellowship
    Open grant
  • 2022 - 2024
    The 3,000 Genomes project: using machine learning and artificial intelligence for robust culture-independent susceptibility testing
    Heidi-CSIRO IDR and AMR Projects
    Open grant
  • 2022 - 2023
    Non-inferiority of low-level (LLD) versus high-level disinfection (HLD) for elimination of bacteria on contaminated ultrasound transducers: A randomised controlled trial (ASUM grant via MNHHS)
    Metro North Hospital and Health Service
    Open grant
  • 2022 - 2024
    Prediction of catheter associated bloodstream infection and hospital-onset sepsis events in critically ill adults
    Heidi-CSIRO IDR and AMR Projects
    Open grant
  • 2021 - 2022
    Improving Diagnosis, Management and Prevention of Invasive Meningococcal Disease
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2022
    Peripherally inserted central catheter Innovation to reduce Infections and Clots: the PICNIC trial
    NHMRC Project Grant
    Open grant
  • 2020 - 2021
    Assessing the epidemiology and variation of the variable virulence factor BimABM of Burkholderia pseudomallei in Queensland
    European Society of Clinical Microbiology and Infectious Diseases Study Group Research Grant
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on gut microbiota of hospitalized patients
    Avant Mutual Group Limited
    Open grant
  • 2020
    Rapid detection of resistance genes from Gram-negative bacteria isolated from blood in ICU-admitted patients
    Pathology Queensland - Study, Education & Research Trust Fund
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on the gut microbiome of hospitalized patients
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3
    Merck Sharp & Dohme Australia
    Open grant
  • 2019 - 2021
    Virulence and detection of Escherichia coli that cause neonatal meningitis
    The Children's Hospital Foundation
    Open grant
  • 2019 - 2021
    Rapid point-of-care tests for multidrug resistant bacteria tailored for QLD paediatrics
    The Children's Hospital Foundation
    Open grant
  • 2019 - 2022
    A multifaceted approach to the treatment and prevention of antibiotic-resistant bacterial infections
    NHMRC Early Career Fellowships
    Open grant
  • 2019 - 2023
    Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial (NHMRC Project Grant led by Monash University)
    Monash University
    Open grant
  • 2019 - 2021
    Peripherally inserted central catheter Innovation to reduCe Infections and Clots: the PICNIC trial (NHMRC Project Grant led by Griffith University)
    Griffith University
    Open grant
  • 2019 - 2020
    Rapid detection of resistance genes from gram-negative bacteria isolated from blood in ICU-admitted patients to enable timely and effective treatment
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2023
    Cluster randomised trial of a multimodal intervention to reduce antimicrobial use in residential aged care facilities
    NHMRC MRFF - Antimicrobial Resistance Targeted Call for Research
    Open grant
  • 2018 - 2019
    Evaluation of cefiderocol (S-649266) against Burkholderia pseudomallei isolates from Queensland, Australia
    Shionogi & Company, Limited
    Open grant
  • 2018
    Rapid characterisation of pathogens for personalised antimicrobial selection in critically ill patients
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2018
    Pilot Randomised Controlled Trial of Penicillin versus Flucloxacillin for Definitive Treatment of Invasive Penicillin susceptible Staphylococcus aureas
    Metro North Hospital and Health Service
    Open grant
  • 2015
    Pilot randomised controlled trial of meropenem versus piperacillin-tazobactam for the definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp, ...
    Royal Brisbane and Women's Hospital
    Open grant

Availability

Dr Patrick Harris is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    New diagnostic strategies for antibiotic-resistant infections

    Principal Advisor

    Other advisors: Associate Professor Adam Irwin

  • Doctor Philosophy

    Burkholderia pseudomallei: towards rapid diagnosis and management

    Principal Advisor

    Other advisors: Mr Mark Chatfield

  • Doctor Philosophy

    Clinical impact of rapid molecular diagnostics in the diagnosis of bloodstream infections and sepsis

    Principal Advisor

  • Doctor Philosophy

    Novel technologies for the diagnosis of bloodstream infection: performance and clinical application

    Principal Advisor

  • Doctor Philosophy

    Genomic approaches to the surveillance and control of multidrug resistant Enterobacterales.

    Associate Advisor

    Other advisors: Dr Brian Forde

  • Doctor Philosophy

    Novel trial design in evaluation of antibiotics.

    Associate Advisor

    Other advisors: Mr Mark Chatfield

  • Doctor Philosophy

    Clinical epidemiology and treatment of central nervous system infections in Asia

    Associate Advisor

  • Doctor Philosophy

    Randomised controlled trial of ceftolozane-tazobactam vs meropenem for bloodstream infections

    Associate Advisor

    Other advisors: Dr Brian Forde, Mr Mark Chatfield

  • Doctor Philosophy

    Clinical epidemiology and treatment of central nervous system infections in Asia

    Associate Advisor

  • Doctor Philosophy

    Accelerating pathogen detection and antibiotic resistance prediction in children with suspected sepsis.

    Associate Advisor

    Other advisors: Associate Professor David Whiley, Associate Professor Adam Irwin

  • Doctor Philosophy

    Treatment Strategies for Extended-Spectrum Beta-Lactamase (ESBL) and AmpC-producing Enterobacterales

    Associate Advisor

    Other advisors: Dr Brian Forde, Mr Mark Chatfield

  • Doctor Philosophy

    Early impact antibiotic therapy for carbapenem resistant organisms, guided by rapid diagnostics

    Associate Advisor

  • Doctor Philosophy

    Clinical and laboratory applications of new and emerging methods of diagnosis of infection

    Associate Advisor

  • Doctor Philosophy

    Clinical and laboratory applications of new and emerging methods of diagnosis of infection

    Associate Advisor

Completed supervision

Enquiries

For media enquiries about Dr Patrick Harris's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au